4//SEC Filing
Manning Paul B 4
Accession 0001494695-25-000004
CIK 0001660334other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 7:00 PM ET
Size
17.4 KB
Accession
0001494695-25-000004
Insider Transaction Report
Form 4
Manning Paul B
Director10% Owner
Transactions
- Purchase
Series C Warrant (right to buy)
2025-11-25+687,690→ 687,690 total(indirect: See footnote)Exercise: $6.32Exp: 2030-11-25→ Common Stock (687,690 underlying) - Purchase
Common Stock
2025-11-25$4.24/sh+1,375,380$5,835,050→ 3,958,189 total - Purchase
Common Stock
2025-11-25$4.24/sh+2,750,762$11,670,108→ 3,348,372 total(indirect: See footnote) - Purchase
Series C Warrant (right to buy)
2025-11-25+343,845→ 343,845 totalExercise: $6.32Exp: 2030-11-25→ Common Stock (343,845 underlying)
Holdings
- 89,187(indirect: By Trust)
Common Stock
- 25,663(indirect: See footnote)
Common Stock
- 332,433(indirect: By Trust)
Common Stock
- 89,187(indirect: By Trust)
Common Stock
- 89,187(indirect: By Trust)
Common Stock
Footnotes (9)
- [F1]Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
- [F2]The shares are held by Mr. Manning jointly with his spouse.
- [F3]The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.
- [F4]These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F5]The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.
- [F6]The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.
- [F7]Immediately exercisable.
- [F8]The reported securities are included within 1,375,380 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
- [F9]The reported securities are included within 2,750,762 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001494695
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 7:00 PM ET
- Size
- 17.4 KB